What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Virus
- Acquired immunodeficiency syndrome
Marina Núñez mainly investigates Immunology, Internal medicine, Hepatitis C, Hepatitis B virus and Hepatitis C virus.
The various areas that Marina Núñez examines in her Immunology study include Adverse effect and Toxicity.
Marina Núñez has included themes like Pegylated interferon and Ribavirin in her Adverse effect study.
Her Internal medicine study combines topics in areas such as Gastroenterology and Efavirenz.
Her Hepatitis C research incorporates themes from Discontinuation and Pharmacology.
Her research brings together the fields of Risk factor and Hepatitis C virus.
Her most cited work include:
- Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study. (253 citations)
- Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir. (251 citations)
- Hepatotoxicity of antiretrovirals: Incidence, mechanisms and management (234 citations)
What are the main themes of her work throughout her whole career to date?
Her main research concerns Immunology, Internal medicine, Virology, Hepatitis C virus and Ribavirin.
Immunology is represented through her Hepatitis C, Viral disease, Sida, Virus and Coinfection research.
Her Internal medicine research includes elements of Gastroenterology and Didanosine.
Her study in the fields of Alanine transaminase under the domain of Gastroenterology overlaps with other disciplines such as Transaminase.
In general Virology study, her work on Hepatitis B, Hepatitis B virus, Lamivudine and Viral load often relates to the realm of In patient, thereby connecting several areas of interest.
Her study in Ribavirin is interdisciplinary in nature, drawing from both Alpha interferon and Zidovudine.
She most often published in these fields:
- Immunology (49.32%)
- Internal medicine (45.89%)
- Virology (38.36%)
What were the highlights of her more recent work (between 2011-2021)?
- Internal medicine (45.89%)
- Virology (38.36%)
- Ribavirin (25.34%)
In recent papers she was focusing on the following fields of study:
Marina Núñez focuses on Internal medicine, Virology, Ribavirin, Pegylated interferon and Faldaprevir.
Her Internal medicine research is multidisciplinary, incorporating elements of Coinfection, Gastroenterology and Oncology.
Her Coinfection study combines topics from a wide range of disciplines, such as Hepatitis B, Viral hepatitis, Hepatitis C, Hepatitis and Hepatitis B virus.
Her Hepatitis B virus study is concerned with Immunology in general.
Her studies deal with areas such as Virus, Hepatitis C virus, Disease and Kidney transplantation as well as Gastroenterology.
Her work in the fields of Virology, such as Hiv hcv coinfection and Hepatitis B virus DNA, intersects with other areas such as Yield.
Between 2011 and 2021, her most popular works were:
- Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease (62 citations)
- Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysis. (53 citations)
- Liver toxicity of antiretroviral drugs. (50 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Virus
- Acquired immunodeficiency syndrome
Her primary areas of study are Internal medicine, Immunology, Kidney disease, Apolipoprotein L1 and Albuminuria.
Her studies deal with areas such as Coinfection and Ribavirin as well as Internal medicine.
Her Coinfection research is multidisciplinary, relying on both Viral hepatitis, Hepatitis C, Liver disease, Alpha interferon and Pegylated interferon.
When carried out as part of a general Immunology research project, her work on Hepatitis B virus is frequently linked to work in Standard definition, therefore connecting diverse disciplines of study.
Marina Núñez interconnects Cystatin C, Proteinuria and Virology in the investigation of issues within Kidney disease.
Her Hepatitis study integrates concerns from other disciplines, such as Hepatitis B, Oncology, Gastroenterology, Acquired immunodeficiency syndrome and Emtricitabine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
